Update shared on08 Sep 2025
Fair value Decreased 2.22%The reduction in Penumbra’s Analyst Price Target reflects a combination of weakening net profit margins and a higher future P/E multiple, with fair value revised down from $310.24 to $303.33.
What's in the News
- Company completed repurchase of 517,763 shares (1.33%) for $100 million under the current buyback, with no shares repurchased in the latest quarter.
- Buyback plan duration extended to December 31, 2025.
- Increased full-year 2025 revenue guidance to $1.355–$1.370 billion, representing 13% to 15% growth over 2024.
- Completed enrollment in STORM-PE clinical trial evaluating Lightning Flash vacuum thrombectomy system for pulmonary embolism.
Valuation Changes
Summary of Valuation Changes for Penumbra
- The Consensus Analyst Price Target has fallen slightly from $310.24 to $303.33.
- The Net Profit Margin for Penumbra has fallen from 15.43% to 14.63%.
- The Future P/E for Penumbra has risen slightly from 53.13x to 54.76x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.